Tayahop, Kianna .
HRN: 27-66-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2025
AMPICILLIN 250MG (VIAL)
10/02/2025
10/08/2025
IVTT
200mg
Q6
Sepsis; R/o CNS Infection
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes